AstriVax Therapeutics

Astrivax therapeutics email format

Verified email-pattern data for Astrivax Therapeutics is currently limited. You can still use the company insights and contact sections below.
AstriVax Therapeutics is a European based, clinical-stage biopharmaceutical company, founded in 2022, that is pioneering immune interventions to treat chronic disease. The company has two prototype prophylactic assets in clinical phase and is developing its therapeutic assets to treat chronic HBV and clear high-risk HPV. AstriVax has a novel DNA-launched viral vector immunotherapy platform, Launch-iT, that is designed to create an inherent adjuvant effect to the target antigens, eliciting durable polyfunctional CD8+ and CD4+ T cell responses and robust humoral immunity. Through Launch-iT, the company has the potential to develop best-in-class immunotherapy treatments.

Company Details

Employees
36
Address
Ambachtenlaan 1, Heverlee,flemish Region 3001,belgium
Industry
Biotechnology Research
HQ
Heverlee, Flemish Region
Looking for a particular AstriVax Therapeutics employee's phone or email?

Astrivax Therapeutics Questions

Top AstriVax Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant